Nov 25, 2021 (AmericaNewsHour) -- Research Nester released a report titled " Sterile injectable drugs market : Global Demand Analysis & Opportunity Outlook 2029" which delivers detailed overview of the global sterile injectable drugs market in terms of market segmentation by type, drug class, application, distribution channel, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global sterile injectable drugs market is expected to witness growth at a considerable CAGR during the forecast period i.e., 2021-2029 on the back of growing prevalence of chronic ailments and need for a specific treatment for the diseases, such as, diabetes, hormonal disorders, communicable diseases, and others. Moreover, the development of newer drugs backed by the increasing medical R&D activities, is projected to significantly boost the market growth throughout the forecast period. Moreover, the spread of COVID-19 has increased the need for better healthcare facilities, and raised the investments in research and development of new drugs, which is projected to boost the market growth.
The global sterile injectable drugs market is segmented by drug class into insulin, hormones, vaccines, peptide antibiotic, cytokines, and others, out of which the vaccine segment is expected to hold a major market share during the forecast period owing to the government initiatives, such as, vaccination drive, to curb the spread of various diseases, including small pox, influenza, rubella, polio, and others. On the basis of distribution channel, the market is branched into hospitals, pharmacy, ambulatory surgical centres, and others. Among these, the hospitals segment is projected to hold a significant share during the forecast period, owing to the growing number of patients, along with the credibility and ease of availability of drugs in the hospitals.
On the basis of region, the global sterile injectable drugs market is segmented into five major regions, including, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Out of these regions, the market in the North America is expected to hold a major share in the market during the forecast period owing to the increasing investment in healthcare infrastructure. As per the data by the World Bank, in North America, over USD 10,050.279 was spent on healthcare per capita, in 2018. Moreover, growing medical advancements along with increased investments in medical R&D activities are anticipated to drive the market growth. The market in the Asia Pacific is anticipated to witness noteworthy growth during the forecast period owing to growing health awareness along with developing public healthcare sector.
Increasing Prevalence of Viral and Bacterial Diseases likely to Drive the Market Growth
The rising incidence of preventable diseases including communicable and lifestyle diseases is expected to drive the market growth. Moreover, constant research activities to discover more effective treatment drugs and novel treatment approach, is further expected to boost the market growth. Additionally, increasing investment and funding towards medical R&D is another factor that contributes towards the growth of the global sterile injectable drugs market.
However, factors such as high cost of injectable drugs, and longer time taken in the approval of drugs, are expected to operate as a key restraint in the growth of the global sterile injectable drugs market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global sterile injectable drugs market which includes company profiling of Sanofi-aventis Groupe (epa:SAN), Pfizer Inc. /zigman2/quotes/202877789/composite PFE -2.33% , GlaxoSmithKline plc /zigman2/quotes/209463850/composite GSK +0.49% , Bausch Health Companies Inc. /zigman2/quotes/207248436/composite BHC +0.56% , Boehringer Ingelheim International GmbH, AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.79% , Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.52% , Novartis AG (swx:NOVN), Progenity, Inc. /zigman2/quotes/219056812/composite PROG -6.77% , and Johnson & Johnson, Inc. /zigman2/quotes/201724570/composite JNJ -0.23% . The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global sterile injectable drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.